Maetzold Derek J 的 Form 4 申報
Castle Biosciences Inc（CSTL），2024/9/5 申報
- 申報編號
- 0001447362-24-000144
- 申報時間
- 2024/9/5
- 交易日
- 2024/9/3-9/4
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 14 筆非衍生性交易。公開市場賣出合計 $5.75 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Maetzold Derek JCIK 0001239501 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/9/3 | Common Stock | S賣出處分 | −417 | $30.05F2 | −$12,530.85 | 99,870 | 直接 | |
| 2024/9/3 | Common Stock | S賣出處分 | −213 | $30.05F2 | −$6,400.65 | 80,843 | 間接 | |
| 2024/9/3 | Common Stock | S賣出處分 | −213 | $30.05F2 | −$6,400.65 | 69,740 | 間接 | |
| 2024/9/3 | Common Stock | S賣出處分 | −69 | $30.05F2 | −$2,073.45 | 8,007 | 間接 | |
| 2024/9/3 | Common Stock | S賣出處分 | −68 | $30.05F2 | −$2,043.4 | 8,005 | 間接 | |
| 2024/9/3 | Common Stock | S賣出處分 | −68 | $30.05F2 | −$2,043.4 | 8,005 | 間接 | |
| 2024/9/3 | Common Stock | S賣出處分 | −68 | $30.05F2 | −$2,043.4 | 8,005 | 間接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −298 | $30.02F9 | −$8,945.96 | 99,572 | 直接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −153 | $30.02F9 | −$4,593.06 | 80,690 | 間接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −153 | $30.02F9 | −$4,593.06 | 69,587 | 間接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −47 | $30.02F9 | −$1,410.94 | 7,960 | 間接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −49 | $30.02F9 | −$1,470.98 | 7,956 | 間接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −49 | $30.02F9 | −$1,470.98 | 7,956 | 間接 | |
| 2024/9/4 | Common Stock | S賣出處分 | −49 | $30.02F9 | −$1,470.98 | 7,956 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $30.000 to $30.185, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 7 筆交易的價格引用這則附註。
- F9
This transaction was executed in multiple trades at prices ranging from $30.000 to $30.065, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 7 筆交易的價格引用這則附註。